Two-hundred and twenty-five House lawmakers April 18 urged the Centers for Medicare & Medicaid Services (CMS) to delay the April 21 release of the overall hospital quality star ratings in order “to provide the necessary time to more closely examine the star rating methodology, analyze its impact on different types of hospitals, and provide more transparent information regarding the calculation of the ratings to determine accuracy.”

The representatives wrote, “While we support the public reporting of provider quality data, we are concerned that the current Star Ratings system may not accurately take into account hospitals that treat patients with low socioeconomic status or multiple complex chronic conditions. We appreciate CMS’s recognition in previous rulemaking of the effects these patient populations have on Medicare Advantage and Part D plans and urge CMS to give similar consideration to the similar effects on the Hospital Compare Star Ratings system.”

The letter was spearheaded by Reps. Jim Renacci, R-Ohio, and Bill Pascrell, D-N.J.

Sixty senators sent a similar letter to CMS last week.

Headline
In this conversation, Amy Lee, president and chief operating officer at Nantucket Cottage Hospital, shares how telehealth is transforming patient care on the…
Headline
An executive order issued by the White House Oct. 19 directs the Department of Health and Human Services, through the National Institutes of Health, to…
Headline
The second listening session in the AHA’s series on disability health will focus on community partnerships and is scheduled for Oct. 28 at 1 p.m. ET. These…
Headline
In this conversation, Brian Peters, CEO of the Michigan Health & Hospital Association, explores the connection between health disparities, healthcare costs…
AHA Cyber Intel
While we may feel inundated with alarming news about escalating cyber threats against healthcare organizations, there is also some good news. Let’s explore how…
Headline
The Food and Drug Administration released draft guidance Sept. 24 that includes recommendations on non-clinical testing, clinical data and labeling for…